George Osol1, Nga Ling Ko2, Maurizio Mandalà3. 1. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont College of Medicine, Given H.S.C. C-217A 89 Beaumont Ave, Burlington, VT, 5405, USA. george.osol@med.uvm.edu. 2. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont College of Medicine, Given H.S.C. C-217A 89 Beaumont Ave, Burlington, VT, 5405, USA. 3. Department of Biology, Ecology and Earth Science, University of Calabria, Cosenza, Italy.
Abstract
PURPOSE OF REVIEW: The goal of this review is to present the newest insights into what we view as a central failure of cardiovascular adaptation in preeclampsia (PE) by focusing on one clinically significant manifestation of maternal endothelial dysfunction: nitric oxide signaling. The etiology, symptoms, and current theories of the PE syndrome are described first, followed by a review of the available evidence, and underlying causes of reduced endothelial nitric oxide (NO) signaling in PE. RECENT FINDINGS: PE maladaptations include, but are not limited to, altered physiological stimulatory inputs (e.g., estrogen; VEGF/PlGF; shear stress) and substrates (L-Arg; ADMA), augmented placental secretion of anti-angiogenic and inflammatory factors such as sFlt-1 and Eng, changes in eNOS (polymorphisms, expression), and reduced bioavailability of NO secondary to oxidative stress. PE is a complex obstetrical syndrome that is associated with maternal vascular dysfunction. Diminished peripheral endothelial vasodilator influence in general, and of NO signaling specifically, are key in driving disease progression and severity.
PURPOSE OF REVIEW: The goal of this review is to present the newest insights into what we view as a central failure of cardiovascular adaptation in preeclampsia (PE) by focusing on one clinically significant manifestation of maternal endothelial dysfunction: nitric oxide signaling. The etiology, symptoms, and current theories of the PE syndrome are described first, followed by a review of the available evidence, and underlying causes of reduced endothelial nitric oxide (NO) signaling in PE. RECENT FINDINGS: PE maladaptations include, but are not limited to, altered physiological stimulatory inputs (e.g., estrogen; VEGF/PlGF; shear stress) and substrates (L-Arg; ADMA), augmented placental secretion of anti-angiogenic and inflammatory factors such as sFlt-1 and Eng, changes in eNOS (polymorphisms, expression), and reduced bioavailability of NO secondary to oxidative stress. PE is a complex obstetrical syndrome that is associated with maternal vascular dysfunction. Diminished peripheral endothelial vasodilator influence in general, and of NO signaling specifically, are key in driving disease progression and severity.
Authors: Stephanie Lankhorst; A H Jan Danser; Anton H van den Meiracker Journal: Am J Physiol Regul Integr Comp Physiol Date: 2015-10-28 Impact factor: 3.619
Authors: Adriana M L Pimentel; Natália R Pereira; Cristiane A Costa; Giovanni E Mann; Viviane S C Cordeiro; Roberto S de Moura; Tatiana M C Brunini; Antônio Cláudio Mendes-Ribeiro; Angela C Resende Journal: Hypertens Res Date: 2013-04-11 Impact factor: 3.872
Authors: Felipe Vadillo-Ortega; Otilia Perichart-Perera; Salvador Espino; Marco Antonio Avila-Vergara; Isabel Ibarra; Roberto Ahued; Myrna Godines; Samuel Parry; George Macones; Jerome F Strauss Journal: BMJ Date: 2011-05-19
Authors: Eugene D Albrecht; Jeffery S Babischkin; Graham W Aberdeen; Marcia G Burch; Gerald J Pepe Journal: Am J Physiol Heart Circ Physiol Date: 2021-03-05 Impact factor: 4.733
Authors: Amanda K Mauro; Nauman Khurshid; Danielle M Berdahl; Amanda C Ampey; Daniel Adu; Dinesh M Shah; Derek S Boeldt Journal: J Endocrinol Date: 2021-02 Impact factor: 4.286
Authors: Olivia K Travis; Geilda A Tardo; Chelsea Giachelli; Shani Siddiq; Henry T Nguyen; Madison T Crosby; Tyler Johnson; Andrea K Brown; Jan M Williams; Denise C Cornelius Journal: Pregnancy Hypertens Date: 2021-05-14 Impact factor: 2.494